TP53 and esophageal squamous cell carcinoma: Additionally, Matsumoto et al. [80] reveal S392 phosphorylation in over 50% of TP53-positive (indicative of TP53 mutation; 90/137 tumors) esophageal squamous cell carcinomas (ESCCs) by immunohistochemistry.